RESEARCH TRIANGLE PARK, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the “Company”) (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy circular dated April 29, 2024 (the “Circular”) for the Annual General Meeting of Shareholders were elected as directors of the Company at the Annual General Meeting of Shareholders held in New York, New York on June 25, 2024.
Detailed results of the vote for the election of directors are set out below:
Name of Nominee | Votes For | % Votes For | Votes Withheld | % Votes Withheld |
Dr. Khalid Islam | 10,100,238 | 96.45% | 371,270 | 3.54% |
Mr. Chris A. Rallis | 9,688,517 | 92.52% | 782,991 | 7.47% |
Mr. Marco Brughera | 9,801,305 | 93.59% | 670,203 | 6.40% |
Dr. Jodi Cook | 8,991,182 | 85.86% | 1,480,326 | 14.14% |
Mr. Rostislav Raykov | 9,859,679 | 94.15% | 611,829 | 5.84% |
Shareholders voted 97.96% in favour of appointing Haskell & White LLP as auditors and authorizing the directors to fix the auditor remuneration, 93.87% in favour of the compensation paid to the Company’s named executive officers.
For further information, please contact:
Rosty Raykov
Chief Executive Officer
Fennec Pharmaceuticals Inc.
T: (919) 636-5144
Last Trade: | US$5.20 |
Daily Change: | 0.06 1.17 |
Daily Volume: | 48,943 |
Market Cap: | US$142.270M |
August 13, 2024 August 05, 2024 May 14, 2024 March 21, 2024 |
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MOREAmneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB